Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$0.42 - $0.72 $18,361 - $31,476
43,717 Added 90.66%
91,937 $58,000
Q3 2023

Oct 13, 2023

BUY
$0.6 - $1.53 $28,932 - $73,776
48,220 New
48,220 $29,000
Q1 2023

Apr 28, 2023

BUY
$1.2 - $2.73 $217,318 - $494,400
181,099 Added 1210.23%
196,063 $265,000
Q4 2022

Feb 02, 2023

SELL
$1.71 - $3.61 $211,470 - $446,437
-123,667 Reduced 89.21%
14,964 $28,000
Q3 2022

Oct 31, 2022

BUY
$1.9 - $8.63 $168,507 - $765,377
88,688 Added 177.58%
138,631 $341,000
Q2 2022

Jul 29, 2022

BUY
$2.13 - $9.01 $84,352 - $356,814
39,602 Added 382.96%
49,943 $122,000
Q1 2022

Apr 29, 2022

BUY
$6.28 - $15.59 $19,229 - $47,736
3,062 Added 42.07%
10,341 $82,000
Q4 2021

Feb 07, 2022

SELL
$14.7 - $28.67 $374,600 - $730,597
-25,483 Reduced 77.78%
7,279 $111,000
Q3 2021

Nov 01, 2021

SELL
$24.31 - $33.6 $98,431 - $136,046
-4,049 Reduced 11.0%
32,762 $931,000
Q2 2021

Aug 12, 2021

BUY
$26.09 - $40.4 $517,495 - $801,334
19,835 Added 116.84%
36,811 $1.24 Million
Q1 2021

May 13, 2021

SELL
$33.06 - $56.93 $463,435 - $798,044
-14,018 Reduced 45.23%
16,976 $649,000
Q4 2020

Feb 04, 2021

BUY
$39.09 - $57.4 $151,825 - $222,941
3,884 Added 14.33%
30,994 $1.3 Million
Q3 2020

Nov 09, 2020

BUY
$28.43 - $44.67 $84,039 - $132,044
2,956 Added 12.24%
27,110 $1.18 Million
Q2 2020

Jul 20, 2020

BUY
$11.71 - $30.29 $61,957 - $160,264
5,291 Added 28.05%
24,154 $732,000
Q1 2020

Apr 30, 2020

BUY
$7.64 - $27.5 $144,113 - $518,732
18,863 New
18,863 $258,000
Q2 2019

Jul 29, 2019

SELL
$17.37 - $26.27 $93,051 - $140,728
-5,357 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$10.65 - $25.75 $57,052 - $137,942
5,357 New
5,357 $125,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.